Cargando…

Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma

On rare occasions, secondary Epstein–Barr virus (EBV)-associated B-cell lymphoma can develop in patients with angioimmunoblastic T-cell lymphoma (AITL). Here, we describe the tumor microenvironment and mutation features of a patient with EBV + large B-cell lymphoma (LBCL) secondary to AITL. He was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fen, Li, Wenyu, Cui, Qian, Chen, Yu, Liu, Yanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354849/
https://www.ncbi.nlm.nih.gov/pubmed/35938041
http://dx.doi.org/10.3389/fgene.2022.940513
_version_ 1784763162111770624
author Zhang, Fen
Li, Wenyu
Cui, Qian
Chen, Yu
Liu, Yanhui
author_facet Zhang, Fen
Li, Wenyu
Cui, Qian
Chen, Yu
Liu, Yanhui
author_sort Zhang, Fen
collection PubMed
description On rare occasions, secondary Epstein–Barr virus (EBV)-associated B-cell lymphoma can develop in patients with angioimmunoblastic T-cell lymphoma (AITL). Here, we describe the tumor microenvironment and mutation features of a patient with EBV + large B-cell lymphoma (LBCL) secondary to AITL. He was admitted to hospital due to a 1-year history of fever and enlarged right inguinal lymph nodes. A biopsy of the right inguinal lymph node demonstrated that numerous diffuse medium-sized atypical lymphocytes proliferated, together with increased extrafollicular follicular dendritic cell meshwork, and the lymphocytes expressed CD3, CD4, BCL6, CD10, PD-1, CXCL13, and Ki-67 (75%). Thus, a diagnosis of AITL was made. However, the disease progressed following treatment by CHOP regimen (cyclophosphamide, adriamycin, vincristine, and prednisone). Biopsy showed that most of the cells were positive for CD20 staining and IgH rearrangement. Analysis of 22 kinds of immune cells showed that the numbers of activated NK cells and activated memory T cells increased, while the T-follicular helper population decreased in the transformed sample. In addition, compared with the primary sample, RHOA (G17V) mutation was not detected, while JAK2 and TRIP12 gene mutations were detected in the transformed sample. Overall, we described the immune microenvironment and mutation features of a patient with EBV + LBCL secondary to AITL. This study will help us to understand the mechanisms by which AITL transforms to B-cell lymphoma.
format Online
Article
Text
id pubmed-9354849
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93548492022-08-06 Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma Zhang, Fen Li, Wenyu Cui, Qian Chen, Yu Liu, Yanhui Front Genet Genetics On rare occasions, secondary Epstein–Barr virus (EBV)-associated B-cell lymphoma can develop in patients with angioimmunoblastic T-cell lymphoma (AITL). Here, we describe the tumor microenvironment and mutation features of a patient with EBV + large B-cell lymphoma (LBCL) secondary to AITL. He was admitted to hospital due to a 1-year history of fever and enlarged right inguinal lymph nodes. A biopsy of the right inguinal lymph node demonstrated that numerous diffuse medium-sized atypical lymphocytes proliferated, together with increased extrafollicular follicular dendritic cell meshwork, and the lymphocytes expressed CD3, CD4, BCL6, CD10, PD-1, CXCL13, and Ki-67 (75%). Thus, a diagnosis of AITL was made. However, the disease progressed following treatment by CHOP regimen (cyclophosphamide, adriamycin, vincristine, and prednisone). Biopsy showed that most of the cells were positive for CD20 staining and IgH rearrangement. Analysis of 22 kinds of immune cells showed that the numbers of activated NK cells and activated memory T cells increased, while the T-follicular helper population decreased in the transformed sample. In addition, compared with the primary sample, RHOA (G17V) mutation was not detected, while JAK2 and TRIP12 gene mutations were detected in the transformed sample. Overall, we described the immune microenvironment and mutation features of a patient with EBV + LBCL secondary to AITL. This study will help us to understand the mechanisms by which AITL transforms to B-cell lymphoma. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9354849/ /pubmed/35938041 http://dx.doi.org/10.3389/fgene.2022.940513 Text en Copyright © 2022 Zhang, Li, Cui, Chen and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Zhang, Fen
Li, Wenyu
Cui, Qian
Chen, Yu
Liu, Yanhui
Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
title Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
title_full Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
title_fullStr Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
title_full_unstemmed Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
title_short Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
title_sort case report: immune microenvironment and mutation features in a patient with epstein–barr virus positive large b-cell lymphoma secondary to angioimmunoblastic t-cell lymphoma
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354849/
https://www.ncbi.nlm.nih.gov/pubmed/35938041
http://dx.doi.org/10.3389/fgene.2022.940513
work_keys_str_mv AT zhangfen casereportimmunemicroenvironmentandmutationfeaturesinapatientwithepsteinbarrviruspositivelargebcelllymphomasecondarytoangioimmunoblastictcelllymphoma
AT liwenyu casereportimmunemicroenvironmentandmutationfeaturesinapatientwithepsteinbarrviruspositivelargebcelllymphomasecondarytoangioimmunoblastictcelllymphoma
AT cuiqian casereportimmunemicroenvironmentandmutationfeaturesinapatientwithepsteinbarrviruspositivelargebcelllymphomasecondarytoangioimmunoblastictcelllymphoma
AT chenyu casereportimmunemicroenvironmentandmutationfeaturesinapatientwithepsteinbarrviruspositivelargebcelllymphomasecondarytoangioimmunoblastictcelllymphoma
AT liuyanhui casereportimmunemicroenvironmentandmutationfeaturesinapatientwithepsteinbarrviruspositivelargebcelllymphomasecondarytoangioimmunoblastictcelllymphoma